المؤلفون: Sakemura RL; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Hefazi M; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Cox MJ; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Siegler EL; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Sinha S; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Hansen MJ; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Stewart CM; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.; Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota., Feigin JM; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Manriquez Roman C; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota., Schick KJ; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Can I; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Tapper EE; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Horvei P; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Adada MM; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Bezerra ED; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Kankeu Fonkoua LA; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Ruff MW; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Department of Neurology, Mayo Clinic, Rochester, Minnesota., Forsman CL; T Cell Engineering, Mayo Clinic, Rochester, Minnesota., Nevala WK; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Boysen JC; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Tschumper RC; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Grand CL; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah., Kuchimanchi KR; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah., Mouritsen L; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah., Foulks JM; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah., Warner SL; Sumitomo Dainippon Pharma Oncology, Inc. Lehi, Utah., Call TG; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Ding W; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Kay NE; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Kenderian SS; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Department of Immunology, Mayo Clinic, Rochester, Minnesota.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota.

المصدر: Cancer immunology research [Cancer Immunol Res] 2023 Sep 01; Vol. 11 (9), pp. 1222-1236.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen* , Neoplasms*, Humans ; Axl Receptor Tyrosine Kinase ; Proto-Oncogene Proteins ; Receptor Protein-Tyrosine Kinases/genetics

المؤلفون: Sakemura R; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Bansal A; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Siegler EL; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Hefazi M; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Yang N; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Department of Infectious Disease, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P.R. China., Khadka RH; Department of Immunology, Mayo Clinic, Rochester, Minnesota.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota., Newsom AN; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota., Hansen MJ; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Cox MJ; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Manriquez Roman C; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota., Schick KJ; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota., Can I; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota., Tapper EE; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Nevala WK; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Adada MM; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Bezerra ED; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Kankeu Fonkoua LA; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Horvei P; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Division of Pediatric Bone Marrow Transplant, University of California, San Francisco, San Francisco, California., Ruff MW; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.; Department of Neurology, Mayo Clinic, Rochester, Minnesota., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Pandey MK; Department of Radiology, Mayo Clinic, Rochester, Minnesota., DeGrado TR; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Suksanpaisan L; Imanis Life Sciences, Rochester, Minnesota., Kay NE; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Peng KW; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota., Russell SJ; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota., Kenderian SS; T Cell Engineering, Mayo Clinic, Rochester, Minnesota. kenderian.saad@mayo.edu.; Division of Hematology, Mayo Clinic, Rochester, Minnesota.; Department of Immunology, Mayo Clinic, Rochester, Minnesota.; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota.

المصدر: Cancer immunology research [Cancer Immunol Res] 2021 Sep; Vol. 9 (9), pp. 1035-1046. Date of Electronic Publication: 2021 Jul 08.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms/*diagnostic imaging , Positron-Emission Tomography/*methods , Receptors, Antigen, T-Cell/*metabolism , Receptors, Chimeric Antigen/*metabolism , Symporters/*analysis, Animals ; Antigens, CD19 ; Disease Models, Animal ; Female ; Humans ; K562 Cells ; Male ; Neoplasms/immunology ; Xenograft Model Antitumor Assays